Oct. 23, 2025
Teijin Pharma Signs Licensing Agreement Giving UK Biotech Firm Exclusive Global Development and Commercialization Rights to Rheumatoid Arthritis Drug Candidate
Teijin Pharma Limited
Press Contact
Corporate Communications
Teijin Limited
pr@teijin.co.jp